Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in immunocompromised patients. Patients with hematological malignancies undergoing conventional chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation are considered at high risk, and Aspergillus spp. represents the most frequently isolated micro-organisms. In the last years, attention has also been focused on other rare molds (e.g., Zygomycetes, Fusarium spp.) responsible for devastating clinical manifestations. The extensive use of antifungal prophylaxis has reduced the infections from yeasts (e.g., candidemia) even though they are still associated with high mortality rates. This paper analyzes concurrent multiple predisposing factors that could favor the onset of fungal infections. Although neutropenia is common to almost all hematologic patients, other factors play a key role in specific patients, in particular in patients with AML or allogeneic HSCT recipients. Defining those patients at higher risk of IFIs may help to design the most appropriate diagnostic work-up and antifungal strategy.
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations / Pagano, Livio; Busca, Alessandro; Candoni, Anna; Cattaneo, Chiara; Cesaro, Simone; Fanci, Rosa; Nadali, Gianpaolo; Potenza, Leonardo; Russo, Domenico; Tumbarello, Mario; Nosari, Annamaria; Aversa, Franco; Lessi, Federica; Criscuolo, Marianna; Farina, Francesca; Tisi, Maria Chiara; Turri, Gloria; Barone, Angelica; Spolzino, Angelica; Del Principe, Maria Ilaria; Quinto, Angela Maria; Di Blasi, Roberta; Maracci, Laura; Nabergoj, Mitja; Cambò, Benedetta; Pegoraro, Anna; Marchesi, Francesco; Pascale, Silvia; Passi, Angela; Carlisi, Melania; Polverelli, Nicola; Beggia, Barbara; Rambaldi, Benedetta; Prezioso, Lucia; Sanna, Marco. - In: BLOOD REVIEWS. - ISSN 0268-960X. - 31:2(2017), pp. 17-29. [10.1016/j.blre.2016.09.002]
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations
Candoni, Anna;Potenza, Leonardo;
2017
Abstract
Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in immunocompromised patients. Patients with hematological malignancies undergoing conventional chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation are considered at high risk, and Aspergillus spp. represents the most frequently isolated micro-organisms. In the last years, attention has also been focused on other rare molds (e.g., Zygomycetes, Fusarium spp.) responsible for devastating clinical manifestations. The extensive use of antifungal prophylaxis has reduced the infections from yeasts (e.g., candidemia) even though they are still associated with high mortality rates. This paper analyzes concurrent multiple predisposing factors that could favor the onset of fungal infections. Although neutropenia is common to almost all hematologic patients, other factors play a key role in specific patients, in particular in patients with AML or allogeneic HSCT recipients. Defining those patients at higher risk of IFIs may help to design the most appropriate diagnostic work-up and antifungal strategy.File | Dimensione | Formato | |
---|---|---|---|
Blood Reviews 2017.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
1.05 MB
Formato
Adobe PDF
|
1.05 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
POSTPRINTpagano2016.pdf
Open access
Tipologia:
Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione
308.5 kB
Formato
Adobe PDF
|
308.5 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris